Bayer

XOFIGO

Manufacturer:

Bayer

Xofigo HCPCS:

A9606

HCPCS Code Descriptor:

Radium ra-223 dichloride, therapeutic, per microcurie

Category:

A Code

Xofigo NDCs:

50419-0208-01

Primary Type:

Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

50419-0208-01

About Xofigo:

XOFIGO is a Radiopharmaceutical drug manufactured by Bayer and administered via the Intravenous route of administration. The A Code: A9606 is aligned to the drug XOFIGO.

ACCESS PRICING AND MORE BY REGISTERING

A9606 Added Date:

January 1, 2015

A9606 Effective Date:

January 1, 2018

A9606 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Xofigo billing and coding information.
Xofigo patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.xofigo-us.com/index.php
XOFIGO prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for XOFIGO. Please check back in a few weeks.